Stryker sees 2023 adjusted EPS $10.25-$10.45, consensus $10.16

Sees 2023 organic net sales growth 9.5%-10.5%. The company said, “Considering our year-to-date results, our strong order book for capital equipment and continued positive procedural trends, we now expect full year 2023 organic net sales growth to be in the range of 9.5% to 10.5% including slightly positive pricing for the year. If foreign exchange rates hold near their current levels, we anticipate net sales will be unfavorably impacted by 0.3% and adjusted net earnings per diluted share will be unfavorably impacted by $0.05 to $0.10 for the full year, both of which are included in our guidance.”